Evidence map›Paper›PMID 41065134›Full record

ArticleFuture science OA2025

Personalized Combined Nutrition & Exercise Intervention in Newly Diagnosed Cancer Patients - a Trial Protocol.

Sebastian Theurich, Timo Niels, Hansjoerg Baurecht, Christine Welker, Annika Tomanek, Ingo Schmidt-Wolf, Christine Greil, Kim Luley, Dirk Forstmeyer, Patrick Jahn and 9 more

Abstract read
In one paragraph

Article in Future science OA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sebastian TheurichDepartment of Medicine III, University Hospital, LMU Munich, Munich, Germany.
Timo NielsDepartment I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.
Hansjoerg BaurechtFaculty of Medicine, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
Christine WelkerFaculty of Medicine, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
Annika TomanekDepartment I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.
Ingo Schmidt-WolfDepartment of Integrated Oncology, Center for Integrated Oncology (CIO), University Hospital of Bonn, Bonn, Germany.
Christine GreilFaculty of Medicine, Department of Internal Medicine, Hematology, Oncology and Stem Cell Transplantation, University Medical Center, Freiburg, Germany.
Kim LuleyDepartment of Hematology and Oncology, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Dirk ForstmeyerDivision of Oncology, Department of Medicine II, University Cancer Center Leipzig (UCCL), Leipzig University Medical Center, Leipzig, Germany.
Patrick JahnHealth Service Research Working Group, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Johann OckengaDepartment of Gastroenterology, Endocrinology and Clinical Nutrition, Klinikum Bremen Mitte, Bremen, Germany.
Wibke JensenDepartment of Oncology and Hematology, BMT with Section Pneumology, Hubertus Wald Tumor Center-University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Katharina GrafDepartment of Oncology and Hematology, Krankenhaus Nordwest, University Cancer Center (UCT), Frankfurt am Main, Germany.
Joachim WiskemannWorking Group Exercise Oncology, Division Medical Oncology, University Hospital and National Center for Tumor Diseases Heidelberg, a partnership between DKFZ and University Medical Center Heidelberg, Heidelberg, Germany.
Caterina FiorentiniDepartment of Preventive Sports Medicine and Sports Cardiology, TUM School of Medicine and Health, TUM University Hospital 'Klinikum rechts der Isar', Technical University of Munich, Munich, Germany.
Nora ZothDepartment I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.
Michael LeitzmannFaculty of Medicine, Institute of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
Freerk T BaumannDepartment I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany.
INTEGRATION Study Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalences of malnutrition and sarcopenia are high already at the time of cancer diagnosis and significantly impact on treatment outcomes. Here, we present the protocol of a multicenter, randomized controlled trial to evaluate the efficacy of personalized, combined nutrition and physical exercise interventions in parallel to first-line cancer treatment. A total of 472 patients will be included and randomized into one of the two study arms. In the intervention arm (A) patients will receive an individualized, needs-adapted preventive and supervised nutritional and exercise program over at least four and up to six months in parallel to cancer treatment. In the control arm (B), patients receive recommendations for physical activity, prescriptions and nutrition counseling in a non-supervised manner. The physical and nutritional status, as well as quality of life will be analyzed in all patients by a multi-dimensional assessment program, termed resource-oriented needs assessment (RONA), before and at distinct time points during and after the intervention period. The primary combined endpoint will be the reduction of needs for supportive care defined by the RONA score at the end of the first-line cancer treatment or after six months of study intervention whichever comes first.

Indexed as

Cancerclinical trial protocolnutrition counsellingoutcomes researchphysical exercise

Identifiers

PMID41065134
PMCPMC12520081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.